Position in PRLD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$317,348
+$191,734 QoQ
Shares Held
59,540
+102.4% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 75 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. PRLD ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in PRLD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $317,348 | 59,540 | Shares | Defined | 2026-08-14 | |
| 2023-12-31 | $125,614 | 29,418 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $274,398 | 88,802 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $86,071 | 19,127 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $102,405 | 19,618 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $216,204 | 31,334 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $605,904 | 48,667 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $1,482,945 | 20,726 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,629,008 | 54,066 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||